These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
288 related items for PubMed ID: 21663423
1. A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa. Kafantaris V, Leigh E, Hertz S, Berest A, Schebendach J, Sterling WM, Saito E, Sunday S, Higdon C, Golden NH, Malhotra AK. J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):207-12. PubMed ID: 21663423 [Abstract] [Full Text] [Related]
3. Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial. Bissada H, Tasca GA, Barber AM, Bradwejn J. Am J Psychiatry; 2008 Oct; 165(10):1281-8. PubMed ID: 18558642 [Abstract] [Full Text] [Related]
4. A double-blind, placebo-controlled study of risperidone for the treatment of adolescents and young adults with anorexia nervosa: a pilot study. Hagman J, Gralla J, Sigel E, Ellert S, Dodge M, Gardner R, O'Lonergan T, Frank G, Wamboldt MZ. J Am Acad Child Adolesc Psychiatry; 2011 Sep; 50(9):915-24. PubMed ID: 21871373 [Abstract] [Full Text] [Related]
5. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study. Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA. J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495 [Abstract] [Full Text] [Related]
6. Olanzapine versus placebo for out-patients with anorexia nervosa. Attia E, Kaplan AS, Walsh BT, Gershkovich M, Yilmaz Z, Musante D, Wang Y. Psychol Med; 2011 Oct; 41(10):2177-82. PubMed ID: 21426603 [Abstract] [Full Text] [Related]
7. [Olanzapine in the treatment of adolescents with anorexia nervosa]. Hein IM, Huyser C. Tijdschr Psychiatr; 2010 Oct; 52(6):417-21. PubMed ID: 20544600 [Abstract] [Full Text] [Related]
8. Olanzapine use for the adjunctive treatment of adolescents with anorexia nervosa. Norris ML, Spettigue W, Buchholz A, Henderson KA, Gomez R, Maras D, Gaboury I, Ni A. J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):213-20. PubMed ID: 21510781 [Abstract] [Full Text] [Related]
9. Olanzapine therapy in anorexia nervosa: psychobiological effects. Brambilla F, Garcia CS, Fassino S, Daga GA, Favaro A, Santonastaso P, Ramaciotti C, Bondi E, Mellado C, Borriello R, Monteleone P. Int Clin Psychopharmacol; 2007 Jul; 22(4):197-204. PubMed ID: 17519642 [Abstract] [Full Text] [Related]
10. An open trial of olanzapine in anorexia nervosa. Barbarich NC, McConaha CW, Gaskill J, La Via M, Frank GK, Achenbach S, Plotnicov KH, Kaye WH. J Clin Psychiatry; 2004 Nov; 65(11):1480-2. PubMed ID: 15554759 [Abstract] [Full Text] [Related]
11. Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial. Kryzhanovskaya L, Schulz SC, McDougle C, Frazier J, Dittmann R, Robertson-Plouch C, Bauer T, Xu W, Wang W, Carlson J, Tohen M. J Am Acad Child Adolesc Psychiatry; 2009 Jan; 48(1):60-70. PubMed ID: 19057413 [Abstract] [Full Text] [Related]
12. Are antipsychotics effective for the treatment of anorexia nervosa? Results from a systematic review and meta-analysis. Kishi T, Kafantaris V, Sunday S, Sheridan EM, Correll CU. J Clin Psychiatry; 2012 Jun; 73(6):e757-66. PubMed ID: 22795216 [Abstract] [Full Text] [Related]
13. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study. Wu RR, Zhao JP, Guo XF, He YQ, Fang MS, Guo WB, Chen JD, Li LH. Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179 [Abstract] [Full Text] [Related]
14. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Tohen M, Kryzhanovskaya L, Carlson G, Delbello M, Wozniak J, Kowatch R, Wagner K, Findling R, Lin D, Robertson-Plouch C, Xu W, Dittmann RW, Biederman J. Am J Psychiatry; 2007 Oct; 164(10):1547-56. PubMed ID: 17898346 [Abstract] [Full Text] [Related]
15. The role of olanzapine in the treatment of anorexia nervosa. Dunican KC, DelDotto D. Ann Pharmacother; 2007 Jan; 41(1):111-5. PubMed ID: 17190846 [Abstract] [Full Text] [Related]
16. Low-dose olanzapine monotherapy in girls with anorexia nervosa, restricting subtype: focus on hyperactivity. Leggero C, Masi G, Brunori E, Calderoni S, Carissimo R, Maestro S, Muratori F. J Child Adolesc Psychopharmacol; 2010 Apr; 20(2):127-33. PubMed ID: 20415608 [Abstract] [Full Text] [Related]
17. A Naturalistic Randomized Placebo-Controlled Trial of Extended-Release Metformin to Prevent Weight Gain Associated With Olanzapine in a US Community-Dwelling Population. Rado J, von Ammon Cavanaugh S. J Clin Psychopharmacol; 2016 Apr; 36(2):163-8. PubMed ID: 26872112 [Abstract] [Full Text] [Related]
18. Does fluoxetine augment the inpatient treatment of anorexia nervosa? Attia E, Haiman C, Walsh BT, Flater SR. Am J Psychiatry; 1998 Apr; 155(4):548-51. PubMed ID: 9546003 [Abstract] [Full Text] [Related]
19. The antidepressant effects of risperidone and olanzapine in bipolar disorder. McIntyre RS, Mancini DA, Srinivasan J, McCann S, Konarski JZ, Kennedy SH. Can J Clin Pharmacol; 2004 Apr; 11(2):e218-26. PubMed ID: 15520475 [Abstract] [Full Text] [Related]
20. Successful olanzapine treatment of anorexia nervosa in a girl with pervasive developmental disorder not otherwise specified. Tateno M, Teshirogi H, Kamasaki H, Saito T. Psychiatry Clin Neurosci; 2008 Dec; 62(6):752. PubMed ID: 19068020 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]